1,2-dipalmitoylphosphatidylcholine has been researched along with ellipticine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalcanti, LP; Torriani, IL | 1 |
| Chakraborty, A; Das, A; Thakur, R | 2 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and ellipticine
| Article | Year |
|---|---|
Thermotropic phase behavior of DPPC liposome systems in the presence of the anti-cancer agent 'Ellipticine'.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Ellipticines; Glass; Lipid Bilayers; Lipids; Liposomes; Methanol; Temperature; Water; X-Ray Diffraction | 2006 |
Photophysical and photodynamical study of ellipticine: an anticancer drug molecule in bile salt modulated in vitro created liposome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Bile Acids and Salts; Cholates; Deoxycholic Acid; Ellipticines; Liposomes; Molecular Structure; Photochemical Processes; Spectrometry, Fluorescence; Taurocholic Acid | 2012 |
The fate of anticancer drug, ellipticine in DPPC and DMPC liposomes upon interaction with HSA: a photophysical approach.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Dimyristoylphosphatidylcholine; Ellipticines; Humans; Liposomes; Serum Albumin; Spectrophotometry, Ultraviolet | 2014 |